Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOnce you click a Mounjaro KwikPen into use for the first time, the shelf life countdown begins — and the window is shorter than most people expect. Each pen remains usable for 30 days after first use, provided it is stored correctly. That figure comes directly from the Mounjaro SmPC published on the electronic Medicines Compendium, and it does not change based on how many doses remain in the pen. The date you open it is the date that matters, and keeping track of it protects both your safety and your treatment. Because Mounjaro is a prescription-only medicine, every aspect of your storage routine (including what to do if you think a pen has been stored incorrectly) is worth discussing with the prescriber overseeing your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The shelf life of Mounjaro once opened is fixed at 30 days from the date of first use. One pen contains four weekly doses, so in normal use the pen should be empty well before that deadline, but the rule still applies if doses are delayed or missed. What this means practically: the moment you administer your first injection, write the date on the pen's label or note it in your phone. Thirty days from that date is the hard cut-off.
It is worth separating this from the unopened shelf life, which is longer and governed by a different set of conditions. If you want to read about storage before the seal is broken, our guide to Mounjaro's shelf life when unopened covers those rules separately. For a broader overview of both stages together, the full Mounjaro shelf life guide brings them into one place.
Never use a pen past its 30-day in-use date, even if doses remain unused. A partial pen that has passed this point should be disposed of safely, your pharmacist can advise on what to do with an opened Mounjaro pen if you are unsure.
Before first use, a Mounjaro KwikPen is stored refrigerated between 2°C and 8°C. Once opened, you have two broad options the SmPC permits: continue keeping it in the fridge (2–8°C) or store it at room temperature. The exact upper temperature limit and maximum duration for room-temperature storage are set out in the Patient Information Leaflet that comes in the box, refer to that, not to third-party summaries, because these conditions are precise.
A detail that trips people up: temperature cycling. Once a pen has come out of the fridge and warmed to room temperature, moving it back into the cold and out again repeatedly is not ideal for the formulation's stability. If you tend to keep your pen in a bag during the week and refrigerate it at weekends, it is worth reading the SmPC conditions carefully or asking your prescriber. The NHS medicines information for tirzepatide is a reliable starting point (see NHS guidance on tirzepatide) though the SmPC on the eMC contains the authoritative storage specifications.
One practical note our prescribers hear often: people keep the pen in the fridge door next to everyday items and assume it must be fine. Fridge door shelves are generally warmer and subject to more temperature variation than the main compartment, so the main body of the fridge is a safer choice.
Visual inspection before each injection is not optional. Tirzepatide solution should appear clear to slightly yellow. Any cloudiness, visible particles or unexpected colour change is a signal to discard the pen and contact your prescriber before administering the dose. Degraded medicine is not simply less effective, it may be unsafe.
This check takes seconds and should become as automatic as the injection itself. If you have ever wondered whether a pen stored in unusual conditions (a hot car, a cold gym bag in winter, or a delay at airport security) is still suitable, the answer is to compare the conditions against the SmPC limits and, where in doubt, to ask. The Mounjaro SmPC on the electronic Medicines Compendium is the definitive reference and is freely accessible to patients.
For a closer look at what changes after the pen is first used and how to handle queries that come up mid-treatment, the page on Mounjaro shelf life after opening addresses some of the more specific scenarios. General context about how tirzepatide works is useful background if you are new to the treatment.
If a pen has been exposed to temperatures outside the permitted range for longer than the SmPC allows, the medicine may have degraded. Degradation does not always change the appearance of the solution, which is why the visual check catches some problems but not all. The safest course is to contact your prescriber or pharmacist as soon as you suspect a storage issue, rather than continuing with doses and hoping for the best.
Reporting unexpected reactions via the MHRA's Yellow Card scheme is also open to patients, this includes reactions you suspect might be linked to a pen that was stored imperfectly. The scheme exists precisely to capture this kind of signal.
If you have broader questions about Mounjaro as a treatment or want to understand the full picture before starting, our Mounjaro overview page covers the medicine in detail. And if storage questions are part of a wider conversation about whether private treatment is right for you, you are welcome to speak to our prescribers through a free consultation, a named clinician will review your situation the same working day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.